Project Details
Description
Project Summary:
Wolbachia are a genus of endosymbiotic bacteria that comprise a promising, cost-effective tool to curb Zika and
dengue arboviral transmission based on two key facets. First, Wolbachia block pathogenic RNA viruses by
inhibiting their replication in arthropods. Second, Wolbachia selfishly alter sperm and egg via a process termed
cytoplasmic incompatibility (CI) that can drive the bacteria into host populations. CI is expressed as embryonic
lethality in crosses between infected males and uninfected females, but this lethality is rescued in crosses
between infected males and infected females, which are the transmitting sex of Wolbachia. Consequently, CI is
deployed in field trials to either suppress mosquito population sizes or replace uninfected populations with
infected individuals resistant to arboviral infection. We recently exposed a genetic model of CI wherein
expression of two genes (cifA and cifB) causes embryonic lethality when expressed in testes, and expression of
one of the same genes (cifA) rescues lethality when expressed in ovaries. Prior to embryonic lethality, several
post-fertilization defects arise including delayed breakdown of the paternal nuclear envelope, mitotic arrest, and
chromatin bridging. As Wolbachia are stripped from sperm during spermatogenesis, the defects caused by cifA
and cifB may be due to uncharacterized pre-fertilization impairments to sperm integrity. Despite four decades of
intense research and current applications to vector control efforts, the details surrounding these pre-fertilization
impairments remain a central enigma. The overarching hypothesis of the proposed research is cifA and cifB
encode proteins that alter sperm integrity to cause CI. In Aim 1, we will use cytochemical, enzymatic, and
transgenic assays to determine the types, strength, and genetic bases of sperm modifications imposed by the
Cif proteins from wMel Wolbachia released in field trials by the World Mosquito Program. In Aim 2, we will
investigate localization patterns of the Cif proteins during spermatogenesis and storage. We will also identify
important interactions between the Cif proteins and either host or Wolbachia proteins. Knockout and transgenic
experiments will interrogate the necessity of the protein-protein interactions for expression of CI. Finally in Aim
3, we will evaluate if the natural CI proteins or protein complex can be experimentally isolated and successfully
injected into uninfected hosts to recapitulate CI and rescue. In these experiments, we will evaluate a novel
association between the Cif proteins and bacteriophage WO particles from Wolbachia. Studies have yet to yield
a mechanistic breakthrough for the natural CI defects afflicting gametes, and the rising interest in deploying
Wolbachia to curb arbovirus transmission necessitates an urgent understanding of the events underpinning the
CI drive system. If successful, this research will fundamentally advance studies of CI modifications and inform
Wolbachia's ongoing efficacy and delivery as a natural tool to control arthropods worldwide.
Status | Finished |
---|---|
Effective start/end date | 1/1/20 → 12/31/24 |
Funding
- National Institute of Allergy and Infectious Diseases: $362,250.00
- National Institute of Allergy and Infectious Diseases: $402,500.00
- National Institute of Allergy and Infectious Diseases: $396,250.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.